VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
PRQR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
PRQRProQR Therapeutics N.V.
$1.10$116M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksPRQRQuarterly Financials

ProQR Therapeutics N.V. (PRQR) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

ProQR Therapeutics N.V. (PRQR) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

PRQR Income Statement

Quarterly statement

PRQR Income Statement

ProQR Therapeutics N.V. (PRQR) annual income statement — 13-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue8.9M2.07M4.69M2.92M3.82M4.52M4.31M3.84M6.3M4.45M3.28M1.37M1.24M697K1.21M888K1.03M1.23M444K1.16M
Revenue Growth %133.27%-54.27%8.85%-24.15%-39.46%1.55%31.15%180.51%407.24%538.45%171.18%54.28%20.8%-43.38%172.75%-23.32%57.34%---
Cost of Goods Sold718.71K705.41K000000000000000000
COGS % of Revenue8.07%34.14%------------------
Gross Profit8.19M1.36M4.69M2.92M3.82M4.52M4.31M3.84M6.3M4.45M3.28M1.37M1.24M697K1.21M888K1.03M1.23M444K1.16M
Gross Margin %91.93%65.86%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %114.44%-69.88%8.85%-24.15%-39.46%1.55%31.15%180.51%407.24%538.45%171.18%54.28%20.8%-43.38%172.75%-23.32%57.34%---
Operating Expenses17.15M15.23M13.79M14.2M16.07M15.34M14.39M12.56M9.9M12.53M9.55M8.76M10.05M10.09M13.67M20.71M16.86M18.27M17.77M15.71M
OpEx % of Revenue192.65%737.24%294.05%487.1%420.91%339.35%334.06%326.8%157.1%281.46%290.86%639.49%808.85%1447.06%1128.9%2332.32%1638.58%1484.57%4002.7%1357.08%
Selling, General & Admin4.28M3.85M3.89M3.12M4.82M3.23M3.91M3.28M3.01M3.45M4.75M3.31M4.14M4.03M2.97M5.36M5.41M4.91M5.32M4.59M
SG&A % of Revenue48.03%186.41%83%107%126.17%71.56%90.85%85.43%47.79%77.57%144.64%241.97%333.47%577.62%245.42%603.49%525.95%398.7%1197.3%396.46%
Research & Development12.88M12.02M9.92M11.08M11.41M12.32M10.61M9.41M7.05M9.28M7.73M5.45M5.91M6.06M10.7M15.35M11.45M13.37M12.46M11.12M
R&D % of Revenue144.62%581.9%211.65%380.1%298.87%272.69%246.37%244.96%111.78%208.61%235.48%397.52%475.38%869.44%883.48%1728.83%1112.63%1085.87%2805.41%960.62%
Other Operating Expenses0-642.07K-28K0-158K-222K-136K-138K-156K-210K-1000K01000-1000
Operating Income-8.97M-13.87M-9.1M-11.28M-12.25M-10.82M-10.08M-8.72M-3.6M-8.07M-6.27M-7.39M-8.81M-9.39M-12.46M-19.82M-15.83M-17.04M-17.33M-14.56M
Operating Margin %-100.72%-671.37%-194.05%-387.1%-320.91%-239.34%-234.06%-226.8%-57.1%-181.46%-190.86%-539.49%-708.85%-1347.06%-1028.9%-2232.32%-1538.58%-1384.57%-3902.7%-1257.08%
Operating Income Growth %26.79%-28.27%9.76%-29.46%-240.25%-33.94%-60.83%-17.93%59.14%14%49.7%62.71%44.35%44.91%28.09%-36.18%-19.91%-40.82%-48.52%-34.02%
EBITDA-8.25M-13.18M-8.42M-10.61M-11.57M-10.14M-9.41M-8.03M-2.89M-7.38M-5.54M-6.75M-8.22M-8.84M-12.26M-19.21M-15.24M-16.47M-16.78M-14.01M
EBITDA Margin %-92.65%-637.79%-179.56%-364.08%-303.22%-224.34%-218.48%-208.9%-45.82%-165.93%-168.7%-492.63%-661.06%-1268.29%-1012.72%-2163.4%-1481.15%-1338.26%-3778.38%-1210.1%
EBITDA Growth %28.73%-30%10.54%-32.2%-300.62%-37.3%-69.86%-18.95%64.84%16.47%54.83%64.87%46.09%46.34%26.9%-37.09%-20.95%-43.6%-52.3%-37.23%
D&A (Non-Cash Add-back)718.71K694K679K671K675K678K671K688K711K691K728K642K594K549K196K612K591K570K552K544K
EBIT-8.97M-13.6M-6.89M-11.01M-12.16M-10.08M-6.49M-8.85M-2.89M-7.65M-1.02M-7.39M-8.81M-9.39M-12.46M-19.82M-15.83M-17.04M-17.33M-14.56M
Net Interest Income154.51K215.49K0327.21K192K455K704K469K513K488K1.1M363K470K-544K-1.23M599K1.16M-822K-909K266K
Interest Income154.51K215.49K0327.21K192K455K704K469K515.59K490.87K824.29K373.56K468.97K00599K1.16M0-890K266K
Interest Expense000000002.59K2.87K-276.71K10.56K-1.03K544K1.23M00822K19K0
Other Income/Expense120.97K270.37K178K278K88K737K776K608K708K420K790K2.01M876K534K-840K-3.41M2.37M2.93M-890K-477K
Pretax Income-8.85M-13.6M-8.92M-11.01M-12.16M-10.08M-9.3M-8.11M-2.89M-7.66M-5.48M-5.38M-7.94M-8.86M-13.3M-23.23M-13.46M-14.11M-18.22M-15.03M
Pretax Margin %-99.36%-658.29%-190.25%-377.56%-318.6%-223.04%-216.04%-210.98%-45.87%-172.02%-166.81%-392.63%-638.38%-1270.44%-1098.27%-2616.55%-1308.36%-1146.22%-4103.15%-1298.27%
Income Tax25.41K01K018K000-200K3K5K41K42K0069K20K7K22K35K
Effective Tax Rate %-0.29%0%-0.01%0%-0.15%0%0%0%6.92%-0.04%-0.09%-0.76%-0.53%0%0%-0.3%-0.15%-0.05%-0.12%-0.23%
Net Income-8.87M-13.6M-8.92M-11.01M-12.18M-10.08M-9.3M-8.11M-2.69M-7.66M-5.48M-5.71M-7.99M-8.93M-13.3M-23.32M-13.7M-14.11M-18.22M-15.05M
Net Margin %-99.65%-658.29%-190.27%-377.56%-319.07%-223.04%-216.04%-210.98%-42.7%-172.09%-166.96%-416.79%-643.04%-1281.64%-1098.02%-2625.9%-1331.39%-1146.14%-4103.83%-1299.4%
Net Income Growth %27.15%-34.96%4.14%-35.74%-352.41%-31.61%-69.71%-42%66.32%14.27%58.77%75.51%41.66%36.69%27.02%-54.97%12.99%-11.91%-37.86%-14.16%
Net Income (Continuing)-8.87M-13.6M-8.92M-11.01M-12.18M-10.08M-9.3M-8.11M-2.69M-7.66M-5.48M-5.42M-7.98M-8.86M-13.3M-23.3M-13.48M-14.12M-18.24M-15.07M
Discontinued Operations00000000000000000000
Minority Interest000000000000-290K-306K-384K-381K-395K-612K-604K-585K
EPS (Diluted)-0.08-0.13-0.09-0.10-0.12-0.10-0.11-0.10-0.03-0.09-0.07-0.07-0.10-0.10-0.14-0.34-0.21-0.20-0.26-0.22
EPS Growth %32.75%-30%22.64%-0.7%-263.64%-5.93%-61.53%-40.85%66.6%4.45%51.36%79.26%52.95%50.6%46.15%-54.55%12.5%20%0%15.38%
EPS (Basic)-0.08-0.13-0.09-0.10-0.12-0.10-0.11-0.10-0.03-0.09-0.07-0.07-0.10-0.10-0.14-0.34-0.21-0.20-0.26-0.22
Diluted Shares Outstanding109.96M105.36M103.01M110.06M105.34M105.3M81.67M81.67M81.67M81.57M78.46M81M80.94M80.89M77.39M71.38M71.36M71.36M71.24M68.26M
Basic Shares Outstanding109.96M105.36M103.01M105.35M105.34M105.3M81.67M81.67M81.67M81.57M78.46M81M80.94M80.89M77.39M71.38M71.36M71.36M71.24M68.26M
Dividend Payout Ratio--------------------